영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
phenindione 50mg tablets
advanz pharma - phenindione - oral tablet - 50mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
phenindione 50mg tablets
alliance healthcare (distribution) ltd - phenindione - oral tablet - 50mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
clexane forte 150mg/1ml solution for injection pre-filled syringes
sanofi - enoxaparin sodium - solution for injection - 150mg/1ml
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
tiloket 50mg capsules
tillomed laboratories ltd - ketoprofen - oral capsule - 50mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
angiox 250mg powder for concentrate for solution for infusion vials
the medicines company uk ltd - bivalirudin - powder for solution for infusion - 250mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
ketoprofen 50mg capsules
sigma pharmaceuticals plc - ketoprofen - oral capsule - 50mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
bivalirudin 250mg powder for concentrate for solution for infusion vials
accord-uk ltd - bivalirudin - powder for solution for infusion - 250mg
필리핀 -
영어 -
FDA (Food And Drug Administration)
actilyse 50mg powder for i.v. infusion
boehringer ingelheim (phils) inc. - human recombinant tissue type plasminogen activator (alteplase) - powder for i.v. infusion - 50mg
영국 -
영어 -
MHRA (Medicines & Healthcare Products Regulatory Agency)
arovi 150mg/1ml solution for injection pre-filled syringes
rovi biotech ltd - enoxaparin sodium - solution for injection - 150mg/1ml
오스트레일리아 -
영어 -
Department of Health (Therapeutic Goods Administration)
bivalirudin sxp bivalirudin (as trifluoroacetate) 250 mg powder for injection vial
southern xp ip pty ltd - bivalirudin, quantity: 250 mg - injection, powder for - excipient ingredients: mannitol; sodium hydroxide - bivalirudin sxp is indicated for use as an anticoagulant: ,? in the treatment of patients with moderate to high risk acute coronary syndromes (acs) (unstable angina/non-st segment elevation myocardial infarction (ua/nstemi) who are undergoing early invasive management, and ,? in patients undergoing percutaneous coronary intervention (pci). ,bivalirudin sxp is intended for use with aspirin. ,a p2y12 antagonist (eg clopidogrel or ticlopidine) may be used in addition to aspirin.